Alpine Associates Management Inc. Axonics, Inc. Transaction History
Alpine Associates Management Inc.
- $2.56 Billion
- Q1 2024
A detailed history of Alpine Associates Management Inc. transactions in Axonics, Inc. stock. As of the latest transaction made, Alpine Associates Management Inc. holds 1,814,771 shares of AXNX stock, worth $122 Million. This represents 4.89% of its overall portfolio holdings.
Number of Shares
1,814,771Holding current value
$122 Million% of portfolio
4.89%Shares
1 transactions
Others Institutions Holding AXNX
# of Institutions
241Shares Held
41.8MCall Options Held
213KPut Options Held
362K-
Vanguard Group Inc Valley Forge, PA5.04MShares$339 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.29MShares$288 Million0.01% of portfolio
-
Fil LTD Hamilton, D01.72MShares$116 Million0.12% of portfolio
-
Mackenzie Financial Corp Toronto Ontario, A61.27MShares$85.2 Million0.13% of portfolio
-
State Street Corp Boston, MA1.19MShares$80.3 Million0.0% of portfolio
About Axonics, Inc.
- Ticker AXNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 49,123,600
- Market Cap $3.3B
- Description
- Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...